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Delay discounting—a behavioral measure of impulsivity defined as a tendency to prefer a small, 
immediate reward over a larger reward delayed in time—has been extensively linked with 
tobacco smoking.  However, the causal direction of this relationship remains unclear.  One 
possibility is that delay discounting may be a marker for an underlying vulnerability to nicotine 
reinforcement—a possibility which can be isolated using an animal model.  In the current study, 
we investigated whether indifference points derived using an adjustable delay procedure of delay 
discounting predicted several indices of nicotine reinforcement in rats, including rate of 
acquisition of nicotine self-administration, break point reached on a progressive ratio schedule of 
reinforcement, or a shift in the dose-response curve.  Stable indifference points were assessed for 
63 male Sprague-Dawley rats, and extreme groups of highly impulsive (HI; n=15) and low 
impulsive (LI; n=11) rats were selected to self-administer nicotine.  Rats responded by nose 
poking for infusions of 0.03 mg/kg nicotine during 1 hour daily sessions.  After a 20 session 
acquisition period, rats completed 3 4-hour progressive ratio sessions, during which the response 
requirement was increased after each infusion earned.  This was followed by 3 1-hour fixed ratio 
sessions at each of 3 nicotine doses, presented in ascending order (0.015, 0.03, and 0.09 mg/kg).  
All but one rat (HI group) acquired stable nicotine self-administration; however, no group 
differences in rate of acquisition were observed.  HI and LI rats did not differ in their responses  
on a progressive ratio schedule or infusions earned at any dose of nicotine, although a significant 
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dose-response effect was observed overall.  Indifference points reassessed after self-
administration were highly correlated with original indifference points, and mean indifference 
points for each group at the second assessment did not differ significantly from baseline 
assessment.  These results suggest that delay discounting is a highly reliable measure, but may 
not be a predictive marker for increased vulnerability to nicotine self-administration in rats. 
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1.0  INTRODUCTION 
Tobacco smoking is a behavioral risk factor for a multitude of diseases, including cardiovascular 
disease, cancer, and chronic obstructive pulmonary disease.  Although public health efforts have 
resulted in a modest decline in smoking rates in recent years, an alarming number of young 
people continue to experiment with smoking, and many go on to become regular smokers.  The 
pharmacological effects of nicotine are thought to underlie the process by which people become 
regular smokers; however, there are marked individual differences in vulnerability to smoking 
(Stanton et al., 2004; Chassin et al., 2000).  Understanding the traits that make some individuals 
prone to becoming regular smokers can help to illuminate pathways of vulnerability and 
facilitate efforts for prevention.   
Delay discounting—the tendency to choose a smaller immediate reward over a larger 
reward delayed in time—is one factor which may predispose some individuals to smoking.  
Delay discounting has been extensively linked with tobacco smoking, but the causal direction 
and underlying mechanisms for this relationship remain unclear.  Animal models provide a 
valuable framework for further exploration of the relationship between delay discounting and 
nicotine-taking behavior, allowing extraneous variables to be carefully controlled.  In this study, 
we investigated whether individual differences in delay discounting in rats predicted differences 
in nicotine self-administration.  We hypothesized that rats with steeper discounting rates (i.e. a 
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greater preference for a smaller, immediate reward) would self-administer more nicotine, and 
acquire this behavior more rapidly, than rats with lower discounting rates.   
1.1 DELAY DISCOUNTING AND SMOKING 
Delay discounting refers to the tendency for individuals to discount the subjective value of a 
reward as it is delayed in time.  Most people will reliably choose a large reward over a small 
reward when both are available immediately.  However, as the larger reward is delayed in time, 
its subjective value decreases, so that at some point the larger magnitude is offset by the decrease 
in value due to delay, and the preference shifts toward the immediate small reward.  Individuals 
discount the value of delayed rewards at different rates, and a steeper discounting curve is 
thought to reflect impulsive choice (Bickel & Marsch, 2001).   
A large literature exists linking discounting of delayed rewards with abuse of drugs, 
including heroin (Madden et al., 1997; Kirby, Petry, & Bickel, 1999), cocaine (Coffey et al, 
2003), alcohol (Vuchinich & Simpson, 1998; Petry, 2001), and tobacco (Mitchell, 1999; 
Reynolds et al., 2004).  Cigarette smokers discount delayed rewards more rapidly than non-
smokers, and the number of cigarettes smoked and total daily nicotine intake are both correlated 
with discounting rate (Ohmura, Takahashi, & Kitamura , 2005).  Interestingly, although current 
smokers consistently make more impulsive choices on delay discounting tasks than non-smokers, 
ex-smokers and non-smokers don’t differ (Bickel, Odum, & Madden, 1999; Skinner, Aubin, & 
Berlin, 2004).  This could be the result of a reversible drug-induced increase in impulsivity, or a 
selection bias in which individuals with steeper discounting rates have greater difficulty quitting 
smoking.   
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Although the relationship between smoking and delay discounting has been clearly 
established, the evidence is largely correlational, and exactly how these factors are related is 
unclear.  Three possibilities exist.  First, delay discounting may be causally related to smoking.  
For example, highly impulsive adolescents may be more likely to try smoking with their friends 
despite parental warnings, and impulsive current smokers may fail to quit because immediate 
relief of withdrawal is valued above long term health outcomes.  In this case, initiation and 
maintenance of smoking could be viewed as a manifestation of the same trait impulsivity which 
was previously manifested in other contexts in the individual’s life.  Although this pathway 
seems intuitive, evidence is indirect at best, and temporal precedence (i.e., impulsivity predicting 
subsequent smoking) has not been clearly established.  A second explanation is that smoking 
may actually increase delay discounting through its pharmacological actions.  Evidence suggests 
that drugs of abuse may increase impulsivity through their induction of neuroplastic changes in 
the brain (Jentsch & Taylor, 1999).  Indeed, Dallery and Locey (2005) found that both acute and 
chronic experimenter-administered nicotine increased delay discounting in rats—an effect which 
endured after 30 days of abstinence.  The third possible explanation is that a third variable could 
be contributing to both steeper delay discounting and smoking.  For example, it is possible that 
delay discounting represents a phenotypic marker for a neurobiological vulnerability toward drug 
reinforcement.  In this case, individual variation in the common neurocircuitry could lead to both 
preference for immediate reward and increased susceptibility to the reinforcing effects of 
nicotine.  If such common neural circuitry is contributing to the relationship between delay 
discounting and smoking, then this relationship might be observed even in contexts in which 
there is not a long term trade-off for engaging in the behavior.   
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It is important to note that the three possible explanations for the relationship between 
delay discounting and smoking described above are not mutually exclusive.  Indeed, individual 
susceptibility to nicotine reinforcement and drug-induced changes in relevant neurocircuitry may 
operate in conjunction to influence smoking trajectories.  However, decomposing the relative 
contributions of each factor is important for understanding vulnerability.  Animal models are 
particularly well-suited for this purpose, because the third variable hypothesis can be isolated 
from the two direct causal pathways.  In animal self-administration models there are no delayed 
consequences to drug taking, so that failure to heed parental warnings or a disregard for future 
health consequences cannot be the mechanism of causality.  Likewise, pharmacologically 
induced changes are eliminated through experimental design; delay discounting is assessed prior 
to drug exposure.  Any relationship that remains in the animal model is therefore likely due to 
common neurobiological substrates influencing both processes.  Assessing whether individual 
differences in delay discounting represent a phenotypic marker for vulnerability to self-
administration was the primary objective of this study.   
Preliminary support for the hypothesis of a common neural substrate comes from a recent 
study, in which delay discounting was found to predict faster acquisition of cocaine self-
administration in rats (Perry et al., 2005).  An earlier study also found a similar effect with 
alcohol, in which choice for the small immediate reward predicted higher levels of alcohol 
consumption in rats (Poulos, Le & Parker , 1995).  Research on behavioral responses to alcohol 
administration has found results along similar lines.  Outbred mice with steeper discounting rates 
exhibited greater locomotor activity after repeated alcohol administration, an effect thought to 
represent sensitization of the midbrain dopaminergic pathway (explained below) (Mitchell et al., 
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2006).  However, no studies have examined the relationship between delay discounting and 
nicotine reinforcement in an animal model.   
1.2 EVIDENCE FOR A COMMON NEURAL SUBSTRATE 
Research into the neural basis of delay discounting and drug reinforcement suggests that 
common pathways may be involved.  Although the exact mechanisms vary, both natural and 
drug rewards increase extracellular dopamine in the region of the nucleus accumbens (Adinoff, 
2004).  This activation of the mesolimbic dopaminergic system is thought to be responsible for 
increasing goal-directed approach behavior, by attaching incentive salience to environmental 
cues associated with the obtained reward (Schultz, 2002; Robinson & Berridge, 1993).  
Sensitization of the nucleus accumbens dopaminergic response to psychomotor stimulants has 
been associated with increased self-administration in animals (Vezina, 2004), and individual 
variability in susceptibility to sensitization is thought to be a central predisposing factor in the 
development of addiction (Robinson & Berridge, 1993).   
Recent evidence suggests that activation of the mesolimbic dopamine system may be 
responsible for assigning additional incentive value to rewards available immediately rather than 
after a delay.  McClure and colleagues (2004) found increased activation of the ventral striatum 
when participants weighed choices that included an immediate option, relative to choices that 
had no immediate option.  In another study, Hariri and colleagues (2006) found that individuals 
with steeper discounting rates exhibited greater BOLD activation in the ventral striatum in 
response to reward than individuals who discounted delayed rewards less steeply.    
 6 
A substantial literature has also implicated serotonin (5-HT) as a critical neural substrate 
of impulsivity (Manuck et al., 2003).  Specifically, serotonergic activity appears to be negatively 
associated with impulsivity (Cardinal et al., 2004), and manipulations which increase serotonin 
also decrease delay discounting (Bizot et al, 1999; Wolff & Leander, 2002).  Although much less 
well studied, indirect evidence also suggests that serotonin may play a moderating role in 
nicotine reinforcement (Olausson, Engel, & Soderpalm, 2002).  Interactions of 5-HT with the 
midbrain dopamine system may provide an explanation for serotonin’s influence on 
reinforcement.  For example, administration of 5-HT agonists has been consistently shown to 
attenuate cocaine induced increases in midbrain extracellular dopamine (Czoty, Ginsberg, & 
Howell, 2002), an effect which has also been found with nicotine (Pierucci, Di Matteo, & 
Esposito, 2004; Grottick, Corrigall, & Higgins, 2001).  Together this evidence suggests that 
serotonergic and dopaminergic systems may be a common source of variation in both delay 
discounting and behavioral sensitization to drugs of abuse.   
1.3 MEASURING DELAY DISCOUNTING IN RATS 
Adjustable delay procedures have been widely used to assess discounting of delayed rewards in 
animal models (Mazur, 1987).  Such procedures require animals to choose between a small 
reward available sooner (SS) or a large reward available later (LL).  The length of the delay to 
the LL reward is adjusted up or down, depending on the animal’s choices, until an “indifference 
point” is reached, indicating that the subjective value of the LL reward is equal to that of the SS 
reward.  This approach for assessing delay discounting in animals is consistent with procedures 
used in humans, in which amount and delay for the LL reward are both varied across many 
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choices, and multiple indifference points can be derived and fitted to a hyperbolic curve (Green 
& Myerson, 2004).  Varying both delay and amount with animals reveals that their discounting 
rates are also best described by hyperbolic functions, suggesting that an equivalent construct is 
being measured (Richards et al., 1997; Mazur, 1987).   
Although hyperbolic discounting functions can be calculated for animals by assessing 
multiple indifference points, many studies rely on single indifference points derived from 
adjustable delay procedures (Perry et al., 2005; Wogar, Bradshaw, & Szabadi, 1993, Dallery& 
Locey, 2005; Wolff & Leander, 2002).  This method does not provide the same extent of 
information as deriving an entire discounting curve, but it has the advantage of being much more 
efficient while retaining the construct validity of more comprehensive approaches.  Therefore, a 
single indifference point derived from an adjustable delay procedure was used in this study.     
1.4 CHARACTERIZING INDIVIDUAL DIFFERENCES IN NICOTINE SELF-
ADMINISTRATION 
Several well-established procedures have been used to assess individual differences in nicotine 
reinforcement.  For example, acquisition of self-administration tested at low doses has been used 
to assess sensitivity to the reinforcing effects of a drug (e.g. Piazza et al., 1989), since only some 
animals will acquire at low doses.  An alternative approach is to examine the rate of acquisition 
in terms of changes in infusions earned over time—a measure which has been shown to be 
related to individual differences in other outcome variables (e.g. nicotinic receptor binding; 
Donny et al., 2004).  Stable responding on a fixed ratio (FR) schedule allows for examination of 
levels of nicotine intake, as well as the regulation of intake at different doses.  Indeed, dose 
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appears to be an important moderator of individual differences in self-administration and its 
relationship to other factors.  For example, in one study rats exhibiting high and low locomotor 
responses to novelty were found to differ in rate of acquisition of cocaine self-administration 
only at the lowest dose tested, while differences in stable FR responding were more pronounced 
at the highest dose tested (Mantsch, Schlussman, & Kreek, 2001).  Accordingly, we assessed 
self-administration on a FR schedule at multiple doses.  Furthermore, we utilized a relatively low 
dose during acquisition in order to maximize individual differences, while still supporting self-
administration (Donny et al, 2004).   
A progressive ratio (PR) schedule of reinforcement, in which the response requirement to 
obtain an infusion is increased after each infusion earned, is thought to provide an indication of 
motivation or incentive salience of a drug (Donny et al., 1999; Richardson & Roberts, 1996).  
Importantly, although infusions earned on FR and PR schedules have been shown to be related 
(Piazza et al., 2000), substantial unexplained variance between them suggests that they may 
reflect relatively distinct aspects of reinforcement (Donny et al., 1999).  Therefore, both types of 
reinforcement schedules were included in this study.   
1.5 SPECIFIC AIMS 
This study tested the hypothesis that impulsive choice predicts individual differences in nicotine 
reinforcement.  To address this question, we assessed the degree to which natural variation in 
delay discounting rates among outbred rats predicted multiple self-administration parameters 
designed to assess individual differences in nicotine reinforcement.  Specifically, we evaluated 
group differences in the rate of acquisition of nicotine-taking behavior, break point on a PR 
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schedule of reinforcement, and infusions earned on an FR schedule at varying doses of nicotine.  
This approach has the advantage of assessing naturally occurring variation in discounting rates 
prior to any drug exposure, and establishing a behavioral framework for further exploration of 
specific neurobiological pathways. 
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2.0  METHOD 
2.1 SUBJECTS 
Subjects were 63 male Sprague-Dawley rats (Harlan farms), aged approximately 3 months and 
weighing 250 to 300 grams at the start of the experiment.  Rats were housed individually in a 
temperature controlled room under a 12 hour reversed light/dark cycle (lights off at 7 a.m.).  
Animals were fed once per day in the home cage following experimental sessions.  The amount 
of food was adjusted each day for each rat to account for any pellets earned during the sessions, 
so that food intake totaled 20 grams per day.  This feeding schedule was designed to keep rats at 
approximately 85% of their free-feeding weight, in order to both control for differences in 
weight gain that might emerge based on choices in the delay discounting procedure, and to 
minimize the degree to which unlimited or pre-session feeding might compete with nicotine as a 
primary reinforcer (Donny et al, 1998).  Rats were given unlimited access to water in the home 
cage.  All sessions were conducted between the hours of 8 a.m. and 6 p.m. 
2.2 DESIGN 
Rats were first screened using a delay discounting procedure (explained below) to determine 
baseline levels of impulsive choice.  Among rats reaching stable indifference points (n=50), 16 
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rats were classified as high impulsive (HI), and 16 rats were classified as low impulsive (LI), 
according to the procedure described below.  This sample size is similar to those used in other 
investigations of individual differences (Piazza et al, 1989; Poulos, Le & Parker, 1995; Perry et 
al, 2005; Diergaarde et al, 2008), and provides adequate power to detect a medium effect size.  
Following group assignment, rats were anesthetized and jugular catheters were surgically 
implanted to allow for intravenous administration of nicotine.  After a brief recovery period rats 
were then allowed to nose poke for infusions of 0.03 mg/kg of nicotine (dose reported as free 
base) during daily 1 hour self-administration sessions.  Self-administration continued for 
approximately 50 sessions, and included an initial acquisition period, a progressive ratio test to 
assess break point, and a within-subjects manipulation of dose to determine dose-response 
curves.  Following the self-administration phase, rats were reassessed on the delay discounting 
procedure to determine the stability of indifference points.  Details of each phase of the study are 
described below. 
2.3 DELAY DISCOUNTING 
2.3.1 Apparatus 
Behavioral testing was carried out in eighteen 25x31x28 operant test chambers (MED 
Associates, Inc., St. Albans, Vermont, USA), each enclosed in a sound-attenuated cubicle.  
During the delay discounting procedure, chambers were fitted with two retractable response 
levers located on the side panel, 15 cm apart and 7 cm above the floor.  A nose poke was 
centered directly between the two levers.  A 45 mg food pellet dispenser delivered pellets into a 
 12 
food tray located directly across from the nose poke on the center of the opposite wall.  No cue 
lights were present above the levers, and no house light was illuminated during the procedure.       
2.3.2 Pretraining 
Prior to beginning the delay discounting procedure, rats underwent several sessions designed to 
train the rats to perform the chained nose poke and lever press response, to train rats to 
discriminate the start of a new trial, and to assess any preliminary side bias toward either lever.  
Animals were first auto-shaped to press the levers for the delivery of food pellets; autoshaping 
was considered successful when rats had pressed each lever a minimum of 25 times in a single 
session.  Rats were then trained to nose poke in order to extend the levers (which served to center 
them between the two levers at the start of each trial).  During the nose poke training, onset of 
each new trial was signaled by the illumination of the nose poke light.  A nose poke within the 
10 second time limit resulted in extension of the levers, and a subsequent lever press was 
followed by retraction of the levers and delivery of a single 45 mg food pellet.  Failure to 
respond within 10 seconds on either operant resulted in termination of the trial (extinction of the 
light or retraction of levers) and no food pellet delivery.  Shaping of the chained nose poke and 
lever press response continued until rats completed 50 successful trials within a session.  After 
successful shaping, a preference test was conducted to determine any initial bias toward one 
lever or the other for each rat.  Side bias was assessed by calculating the percentage of responses 
on each lever when both were presented simultaneously and responses were not reinforced.  Side 
bias was then considered when assigning the smaller sooner (SS) and larger later (LL) levers, so 
that, as a group, the degree of initial preference for the SS lever averaged 50%.  
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2.3.3 Behavioral procedure 
The delay discounting procedure was based upon Mazur’s (1987) adjustable delay paradigm 
described above.  Rats completed one-hour sessions twice per day, five days per week.  Each 
session consisted of a series of choice trials in which a response on one lever was followed by 
immediate delivery of one pellet, and response on the other lever was followed by three pellets 
delivered after a variable delay (2 to 74 seconds).  Lever assignment was counter-balanced 
between rats, but remained constant for each rat for the duration of the study.   
A schematic diagram of the sequence of events for each trial is shown in Figure 1 below.  
The start of each new trial was signaled by the illumination of the nose poke light, consistent 
with the cue conditions present during pre-training.  In addition, the same 10 second time limit 
on responses was imposed.  The absence of a response within this time limit was recorded as an 
omission.   Once a lever was pressed, both levers were retracted and the 60 second inter-trial 
interval began.  In order to avoid introducing a confounding factor that may bias selections, and 
to preserve novel cues for the self-administration procedure, no other cues signaled the response 
selection or the delivery of either the immediate or delayed reward. 
Sessions consisted of 15 blocks of 4 trials each.  The first two trials of each block were 
forced-choice trials (each lever presented alone once), and the final two trials were free-choice 
trials (both levers presented).  The forced-choice trials were designed to insure that rats sampled 
each option before making a selection.  Forced-choice lever presentation occurred in 
pseudorandom order.  At the start of the first session, all delays were set at 10 seconds.  At the 
end of each block of trials, the delay was adjusted up or down depending upon the free choices.  
Two LL choices resulted in a 10% increase in the delay, two SS choices resulted in a 10% 
decrease during the next block of trials, and one choice on each lever resulted in no change.  
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Figure 1.  Procedure for each trial during delay discounting.  
 
Each new session began with the ending delay from the previous session.  Indifference points 
were calculated based on the average adjusting delay for each session according to the criteria 
described below.  Testing continued for 53 sessions, until stable indifference points were reached 
for 50 animals.  Animals reaching stability sooner completed the remaining sessions, in order to 
insure that all animals had equivalent experience within the operant chambers prior to self-
administration.   
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2.3.4 Calculating indifference points 
The average adjusting delay experienced by the rat was calculated for each session, and the 
pattern across sessions was evaluated to determine a stable indifference point.  After completing 
a minimum of 30 sessions, stability was assessed according to the following criteria:  1) a 
coefficient of variation of less than 20% for the average adjusting delay across 5 days, 2) less 
than 20% or 5 seconds change in the average adjusting delay across the next ten days, and 3) 
absence of a visual linear trend over the total 15 day period.  The latter criterion was imposed to 
allow for detection of subtle shifts over time that may not be evident when averages over 
multiple days were being considered.  Once the stability criteria were met, the average adjusting 
delay across the entire 15 day period was calculated as the indifference point.      
2.4 GROUP ASSIGNMENT 
At the conclusion of the delay discounting assessment, animals were assigned to high and low 
impulsivity groups according to the following procedure.  First, rats completing delay 
discounting training and meeting stability criteria were rank ordered by indifference points.  
Those with indifference points in the upper third were considered for assignment to the low 
impulsive (LI) group, and those with indifference points in the bottom third were considered for 
assignment to the high impulsivity (HI) group.  To ensure that the final selected groups 
accurately reflected “high” and “low” impulsivity, the average adjusting delays across all 
completed sessions beginning with session 26 (the earliest session that could be included in the 
indifference point assessment) and continuing through session 53 were also considered.  The 
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percentage of these final 28 sessions for which the average adjusting delay was higher or lower 
than the average indifference point for the population was calculated for each rat.  Rats with 
more than 40% of their average adjusting delays falling below the population average were 
excluded from the low impulsivity group, and rats with more than 40% of their average adjusting 
delays falling above the population average were excluded from the high impulsivity group.  
This resulted in the exclusion of three rats who would have otherwise been assigned to the low 
impulsivity group.  After these exclusions were made, the 16 rats with the lowest indifference 
points were assigned to the HI group, and the 16 rats with the highest indifference points were 
assigned to the LI group.       
2.5 SURGERY 
Rats assigned to the LI and HI groups (n=32) were then implanted with right jugular catheters 
under halothane anesthesia, and were allowed a minimum of seven days healing time before 
beginning self-administration.  Cannulae were flushed daily with 0.1 ml of sterile saline 
containing heparin (30 U/ml) and Timentin (66.67 mg/ml) to maintain catheter patency and 
prevent infection.  In addition, rats received streptokinase (8333 U/ml) for the first four days 
post-surgery.  Catheter patency was tested twice during self-administration by observing loss of 
the righting reflex following an infusion of 200 mg/kg chloral hydrate. 
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2.6 NICOTINE SELF-ADMINISTRATION 
2.6.1 Apparatus 
Sessions took place in the same operant chambers used for delay discounting.  However, the 
internal construction of the chambers was changed.  The two retractable response levers and the 
centering nose poke were removed from the chambers, so that the side panel previously used for 
responding was empty of all operants, with only a red house light located at the top.  On the 
opposite wall, the pellet trough was removed, and two nose pokes were positioned 15 cm apart 
and 3 cm above the floor.  Nose pokes were used as the operant instead of levers to maximize the 
procedural differences between the delay discounting and self-administration sessions.  A white 
stimulus lights was located 5 cm above each nose poke.  A 1 cm diameter hole in the top of the 
chamber gave access to a drug-delivery swivel system, which connected to the implanted 
catheters and allowed nearly unlimited movement throughout the chamber. 
2.6.2 Timeline 
Self-administration took place in the following three stages:  acquisition, PR sessions, and FR 
dose-response manipulation.  The timeline for these procedures is listed in Table 1 below. 
2.6.3 Acquisition 
Sessions were held 1 hour per day, 5 days per week, for approximately 20 sessions.  Responses 
on the active nose poke were reinforced with an infusion of 0.03 mg/kg nicotine bitartrate (dose  
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Table 1.  Timeline for nicotine self-administration procedures. 
 
Stage of Self-
administration 
 
Procedure  
 
Nicotine Dose 
Number of 
Sessions 
 
Acquisition 
 
 
FR 2 
 
(0.03) 
 
10 
 
FR 5 
 
(0.03) 
 
10-13 
 
PR Sessions 
 
 
PR Test 
 
(0.03) 
 
3 
 
FR 5 
 
(0.03) 
 
3 
 
 
Dose-response 
Assessment 
 
FR 5 
 
(0.015) 
 
3 
 
FR 5 
 
(0.03) 
 
3 
 
FR 5 
 
(0.09) 
 
3 
 
Total  
   
35-38 
  
 
reported as free-base), paired with a 15-second illumination of the white cue light located above 
the active nose poke.  The dose of 0.03 mg/kg was used because it has been shown to support 
self-administration, while maximizing individual differences in the rate of acquisition (Donny et 
al., 2004).  The cue light paired with infusion delivery was selected because it is consistent with 
cue conditions used in other studies examining individual differences in nicotine self-
administration (Suto, Austin, & Vezina, 2001; Le et al., 2006), and this stimulus has been shown 
in our laboratory to have minimal primary reinforcing value in the absence of nicotine.  A 60 
second unsignaled time-out period followed infusion delivery, during which responses were 
recorded but not reinforced.  Responses on the inactive nose poke were recorded but had no 
consequence.  Prior studies have demonstrated that rats acquire nicotine self-administration on a 
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FR1 schedule, and that stable and robust responding is maintained at a FR5 schedule (Donny et 
al., 1998; 2000).  Because of the shift to a more natural operant with which the rats had prior 
history, we began with a FR2 for the first 10 days of acquisition.  Beginning on day 11 and 
continuing throughout the remainder of the acquisition period, the response requirement was 
increased to a FR5.  Typical nicotine self-administration procedures involve stepwise increases 
in FR requirement over multiple sessions (e.g. Donny et al., 1998; 1999), and these small 
increases in the FR tend to exaggerate individual differences in nicotine self-administration 
(Lanza et al., 2004).  Acquisition of self-administration was judged to be complete when 
responding favored the active nose poke by a ratio of 2:1, and a minimum of 5 infusions were 
earned per session for the majority of the last five sessions on a FR5.  Animals not acquiring 
self-administration (n=1) were excluded from further analyses.   
2.6.4 Progressive ratio test 
Immediately following the 20 day acquisition period, rats were switched to a PR schedule.  The 
PR test consisted of 3 consecutive 4-hour sessions.   During these sessions, cue conditions and 
dose of nicotine were identical to the acquisition conditions, but the response requirement was 
increased with each successive infusion earned according to the following schedule: 3, 6, 10, 15, 
20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 179, 219, 268, 328, 402, 492.  “Break point” was defined 
as the number of infusions earned prior to an hour elapsing with no infusions, or as the total 
number of infusions earned during the session.  After 3 PR sessions, rats were returned to 
baseline for 3 sessions of self-administering 0.03 mg/kg nicotine on a FR5 schedule of 
reinforcement.  Catheter patency was tested at the conclusion of the progressive ratio sessions; 
animals failing to demonstrate patency (n=7) were excluded from analyses.  
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2.6.5 Dose effects 
Following PR testing, within-subjects dose manipulations were conducted to determine dose-
dependent effects.  During this phase of self-administration, sessions were conducted 7 days per 
week, in order to avoid a period of abstinence prior to testing.  Rats spent 3 days self-
administering each of 3 doses, presented in ascending order, on a FR5 reinforcement schedule.  
Doses were 0.015 (minimum dose that supports self-administration, which may reveal 
differences in sensitivity to the reinforcing effects of nicotine), 0.03 (standard self-administration 
dose), and 0.09 (maximizing primary reinforcing effects, Chaudhri et al., 2006).  At the 
conclusion of the dose manipulation, rats were tested again for catheter patency.  No additional 
rats failed patency at this time. 
2.7 REASSESSMENT OF INDIFFERENCE POINTS 
Following the conclusion of self-administration, rats were then reassessed on the delay 
discounting procedure to determine the stability of indifference points over time.  Operant 
chambers were returned to their original configurations.  Delay discounting sessions identical to 
those conducted during the initial assessment period resumed twice per day, five days per week, 
until new indifference points were determined.  During the first session, the starting delay 
interval was reset to 10 seconds for all rats, in order to avoid biasing new assessments based on 
past performance.  Rats were required to complete a minimum of 10 sessions, after which 
stability was determined according to criterion 1 described above (coefficient of variation of less 
than 20% for the average adjusting delay across five days).  Additional criteria were not used 
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during reassessment since comparisons with prior indifference points were considered to be a 
better indication of stability.  The average adjusting delay over the 5 days during which the 
coefficient of variation first dropped below 20% was used as the new indifference point.   
2.8 STATISTICAL ANALYSES 
A three-way ANOVA (Group X Day X FR) was used to assess change over time in number of 
infusions earned per session during acquisition.  Group differences in slopes across days were 
compared using polynomial contrasts.  In addition, planned comparisons tested for group 
differences on the final day of each FR (days 10 and 20), as well as the change score following 
an increase in FR (day 10 – day 11).  A two-way ANOVA (Group X Session) with polynomial 
contrasts was conducted to assess group differences in break point across sessions.  In addition, 
break points reached on the last two sessions of the PR schedule were averaged, and an 
independent samples t-test was used to determine group differences.  Dose effects were 
evaluated by calculating the average number of infusions earned during the final two sessions for 
each dose.  A two-way (Group X Dose) ANOVA was used to evaluate group differences in 
average number of infusions earned at each dose.  In the case of a significant overall effect, 
independent samples t-tests were used to compare group differences at each individual dose, 
while paired samples t-tests were used to differences between doses.  Finally, the correlation 
between initial indifference points and those determined during reassessment was calculated as 
an index of reliability.  In addition, t-tests were used to determine whether any change in 
indifference points occurred following self-administration among high or low impulsive rats.   
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3.0  RESULTS 
3.1 DELAY DISCOUNTING 
Of the 63 rats who participated in the delay discounting procedure, 4 were removed from the 
study due to equipment failure which interfered with the delivery of the large reward.  A fifth 
animal was removed from the study due to an excessive number of omitted trials (>11 per 
session), which resulted in early termination of more than 20% of his sessions.  By comparison, 
the remainder of the animals failed to respond before the time limit an average of only 2.6 trials 
per session, and they successfully completed 99.3% of their sessions.   
The remaining 58 rats completed between 49 and 53 sessions (M=52.7).  Although all 
rats participated in 53 sessions, the number of successfully completed sessions was slightly lower 
for some animals, since a high number of omitted trials resulted in early termination of the 
session.  Of the 58 rats completing the procedure, 52 rats met criteria 1 and 2 for establishing a 
stable indifference point.  Two of these were excluded because they violated criterion 3, 
demonstrating a decreasing visual trend.  The remaining 50 rats were then assigned to groups 
according to the procedure described above.  Indifference points and standard deviations for the 
50 rats meeting stability criteria are shown in Figure 2. 
The mean indifference point for all 50 rats meeting stability criteria was 27.73 
(SD=10.13).  The indifference points for rats assigned to the HI group ranged from 11.10 to  
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Figure 2. Indifference points (with standard deviations) for all rats meeting stability criteria during 
delay discounting. 
 
21.77 seconds, and indifference points for rats assigned to the LI group ranged from 29.26 to 
59.94 seconds.  Data for each of these groups and the overall sample are presented in Table 2.  
Independent samples t-tests were used to assess differences between HI and LI rats for each 
measure assessed during the delay discounting procedure.  Indifference points for HI rats were 
significantly lower than indifference points for LI rats (t=-9.971, p<0.001), verifying the validity 
of the group assignment procedure.  LI rats took an average of 3 sessions longer than HI rats to 
meet criteria for establishing indifference points, a difference which was statistically significant 
(t=-2.275, p<.05).  Although a trend toward fewer omitted trials among LI rats was observed, 
this difference did not reach significance (t=-1.723, p>0.05).  There was no weight difference 
between LI and HI rats during the time period in which stable indifference points were being 
reached.                    
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Table 2. Mean (and SD) values on measures assessed during delay discounting for high impulsivity 
rats, low impulsivity rats, and the total sample. 
 
 
Variable High Impulsivity 
(n=16) 
Low Impulsivity 
(n=16) 
Total Sample    
(n=50) 
Indifference Point** 
 
17.49 (3.29) 38.96 (7.96) 27.73 (10.13) 
Omissions 
 
2.18 (1.43) 3.18 (1.82) 2.50 (1.58) 
#Sessions to Criteria* 
 
41.13 (2.03) 44.13 (4.87) 43.54 (4.34) 
Average Weight for 
Sessions 40 to 48 
305.73 (15.08) 306.16 (18.50) 309.68 (17.38) 
*Indicates a significant difference at the p<0.05 level. 
**Indicates a significant difference at the p<0.001 level. 
 
 
3.2 NICOTINE SELF-ADMINISTRATION 
3.2.1 Acquisition 
Seven of the 32 rats (2 HI; 5 LI) failed to demonstrate patent catheters at the first patency test.  
Their data was subsequently dropped from analysis.  An additional rat (HI) failed to acquire self-
administration, and his data were also dropped.  This resulted in 13 rats remaining in the HI 
group, and 11 rats remaining in the LI group.  Mean daily infusions earned by each group during 
acquisition are presented in Figure 3; responses on the active and inactive nose pokes are 
presented in Figure 4.  The main effect of day on number of infusions earned was significant, 
F(9,198)=35.146, p<.001, as were both linear and quadratic contrasts for day (p’s<.001).  The 
main effect of FR was also significant, F(1,22)=6.857, p<.05, with rats earning significantly  
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Figure 3.  Mean infusions (with standard errors) for each day during acquisition for rats high and 
low in impulsivity. 
 
 
 
Figure 4.  Mean active and inactive nose pokes (with standard errors) for each day during acquisition 
for rats high and low in impulsivity.    
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more infusions during the FR5 condition than during the FR2 condition, t(23)=2.610, p<.05.  
There was no main effect of impulsivity group, F(1,22)=.091, ns, nor was there a significant 
group by FR interaction, F(1,22)=.394, ns.  There was a significant group by day interaction, 
F(9,198)=2.020, p<.05.  However, neither linear nor quadratic contrasts were significant (both 
p’s>.10).  Planned comparisons revealed that there were no significant differences between high 
and low impulsivity groups for number of infusions earned on day 10, t(22)=.301, ns, or 20, 
t(22)=.236, ns, nor was there any significant group difference in the change in infusions earned 
between days 10 and 11, when the increase to the FR5 schedule was initiated, t(22)=.612, ns.  
Likewise, there were no significant differences between groups for number of active nose poke 
responses, either as a main effect or an interaction. 
3.2.2 Progressive ratio test 
Several rats failed to reach a break point on the progressive ratio test within the allotted time 
(Table 3).  However, there were no significant group differences for the number of rats reaching 
a break point for any session (χ² = 2.970, .839, and .509 for sessions 1, 2, and 3 respectively; all 
ns).  Mean infusions earned prior to reaching a break point for each group are presented in Figure 
5.  For those rats not reaching a break point, total infusions earned during the session were used 
instead.  There was no main effect of session number, F(2,44)=1.685, ns, no main effect of 
group, F(1,22)=.059, ns, and no group by session interaction, F(2,44)=2.396, p>.10.  When 
considering just the mean of the last two sessions, the HI group earned an average of 10.85 
(SD=3.70) infusions prior to reaching break point, while rats in the LI group earned an average 
of 9.86 (SD=4.06) infusions.  This difference was not significant, t(22)=.620, ns. 
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Table 3.  Number of rats (and %) from each group and the total sample failing to reach break point 
during each progressive ratio session. 
 
 
Progressive Ratio 
Session 
High Impulsivity 
(n=13) 
Low Impulsivity 
(n=11) 
Total Sample    
(n=24) 
Session 1 
 
1 (7.7%) 4 (36.4%) 5 (20.8%) 
Session 2 
 
3 (23.1%) 1 (9.1%) 4 (16.7%) 
Session 3 
 
3 (23.1%) 4 (36.4%) 7 (29.2%) 
 
 
 
 
 
 
 
 
 
Figure 5.  Mean break point (with standard errors) during each progressive ratio session for rats 
high and low in impulsivity. 
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3.2.3 Dose effects 
Mean infusions earned during the last two sessions at each dose are presented in Figure 6.  
Repeated-measures ANOVA revealed a main effect of dose, F(2,44)=86.675, p<.001, with 
significant linear and quadratic contrasts (both p’s<.001).  Post-hoc comparisons indicated that 
rats earned significantly more infusions at the 0.015 dose than at the 0.03 or 0.09 doses, 
t(23)=3.936 and 10.403, respectively, both p’s≤.001.  In addition, rats earned more infusions at 
the 0.03 dose than at the 0.09 dose, t(23)=9.808, p<.001.  However, there were no significant 
group differences, either as a main effect, F(1,22)=.012, ns, or an interaction, F(2,44)=.059, ns. 
 
 
 
Figure 6.  Mean infusions earned (with standard errors) during the last two sessions at each dose for 
rats high and low in impulsivity. 
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3.3 REASSESSMENT OF INDIFFERENCE POINTS 
All but one of the 25 rats met the reassessment stability criteria described above.  Rats reached 
stability in an average of 12.13 sessions (S.D.=2.71).  New indifference points ranged from 
12.40 to 45.36 seconds.  For the HI group, indifference points ranged from 12.40 to 38.04 
seconds, and for the LI group, indifference points ranged from 27.89 to 45.36 seconds.  As 
expected, new indifference points were significantly higher in the LI group compared with the 
HI group, t(22)=4.559, p<.001.  Comparisons between indifference point assessments at Time 1 
and Time 2 are presented in Table 4.  Although there was a trend toward higher indifference 
points at Time 2 among the HI rats, this comparison failed to reach significance.  Likewise, there 
was no change between Time 1 and Time 2 in indifference points among rats in the LI group, or 
in the sample as a whole.   
 
 
Table 4.  Mean (and SD) indifference points assessed during delay discounting at Time 1 and Time 2, and t 
statistics for paired samples comparisons among high impulsivity rats, low impulsivity rats, and the total 
sample. 
 
Group Indifference Point 
Time 1 
Indifference Point 
Time 2 
t statistic p value 
High Impulsivity 
(n=14) 
17.64 (3.24) 21.98 (8.61) 2.079 .058 
Low Impulsivity 
(n=10) 
37.30 (8.83) 37.51 (7.65) .053 .959 
Total Sample 
(n=24) 
 25.83 (11.60)   28.45 (11.22) 1.257 .221 
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Individual indifference points at Time 1 were highly related to indifference points at 
Time 2 (r=.599, p<.01).  However, analysis of influence statistics indicated that one rat was a 
statistical outlier (Cook’s Di=2.9).  When this rat was dropped from the analysis, the correlation 
between Time 1 and Time 2 measures improved (r=.771, p<.001; Figure 7).   
      
 
 
Figure 7.  Indifference points reassessed at Time 2 plotted against indifference points assessed at 
Time 1 for rats meeting stability criteria at both time points.  (One statistical outlier has been 
removed).  
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4.0  DISCUSSION 
This study utilized a rat model of nicotine self-administration to evaluate whether pre-existing 
individual differences in delay discounting predicted several different aspects of nicotine taking 
behavior.  Specifically, we hypothesized that steeper discounting of delayed rewards would 
contribute to increased infusions earned during acquisition of nicotine self-administration, higher 
break point on a progressive ratio schedule, and an upward shift in the dose-response curve.  
Contrary to our expectations, we found no differences between the high and low impulsivity 
groups on any measure of self-administration.  This is surprising, given the literature supporting 
this prediction (Perry et al, 2005; Poulos, Le, & Parker, 1995; Mitchell et al., 2006).      
Given the lack of association between impulsivity level and any measure of nicotine self-
administration, one potential explanation is that there was insufficient variability present within 
the single outbred strain of rats to permit an association to be detected.  However, this is unlikely 
given that a substantial amount of variability was observed in the measure of indifference points 
and in the propensity to self-administer nicotine.  For example, among rats maintaining patency 
throughout the study, average infusions earned during week 4 of the acquisition period ranged 
from 11.0 to 31.4, and average break points during sessions 2 and 3 on a progressive ratio 
schedule ranged from 3.5 to 16.5, demonstrating variability comparable to that observed in other 
studies (Donny et al, 1999), with a sufficient range for examining individual differences.  
Furthermore, several other studies have found significant relationships between baseline 
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characteristics and drug self-administration outcomes using a single outbred strain of rats (Perry 
et al, 2005; Poulos, Parker, & Le, 1998; Diergaarde et al, 2008; Suto, Austin, & Vezina, 2001; 
Piazza et al, 1989). 
The lack of significant findings in the present study also raises concern about the 
reliability and validity of the measures used.  However, several points address these concerns.  
First, the delay discounting procedure used was quite similar to procedures used in other studies, 
in which associations with relevant neurocircuitry have been demonstrated (Bizot et al, 1999; 
Mobini et al, 2000; Wolff & Leander, 2002).  The indifference points in the current study were 
somewhat larger than those found in other studies (e.g. Dallery & Locey, 2005; Perry et al, 
2005), although strain differences and slight procedural differences are likely to have played a 
role.  For example, the delay discounting procedure used in the current study did not employ any 
visual or auditory cues when a response selection was made or the reward was delivered, but rats 
still readily learned the procedure, and it is unlikely that these differences would detract from the 
validity of the measure.  In addition, the observed indifference points were well within the range 
constrained by the task, suggesting that floor and ceiling effects did not compromise the validity 
of the measure.            
The current study evaluated the test-retest reliability of the delay discounting procedure, 
and the strength of this reliability is particularly notable.  Nearly nine weeks elapsed between the 
completion of the first delay discounting assessment and the start of the second assessment—an  
interval of time more than twice as long as that used in other studies to determine test-retest 
reliability (Diergaarde et al, 2008).  This strongly supports the use of the indifference point 
measure obtained in the current study as a stable, trait-like measure of delay discounting.  In 
addition, the strong association between the two assessments is unlikely to have been biased by 
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the testing procedure itself, since delay intervals were reset to 10 seconds at the start of the 
second assessment, and then were allowed to vary freely based on the rats’ behavior.  Because of 
this strategy, rats were required to shift the delays back to their preferred indifference point 
through choices favoring one lever, and then hold their indifference points constant through a 
selection pattern approximating 50% responses on each lever.  Furthermore, it is notable that the 
strong association between indifference points obtained at Time 1 and Time 2 was not disrupted 
by the intervening performance of another operant procedure (self-administration), further 
attesting to the stability of the measure.  The fact that indifference points did not shift as a 
consequence of the pharmacological effects of nicotine exposure is surprising, given that 
previous studies have observed nicotine-induced increases in delay discounting (Dallery & 
Locey, 2005).  However, the nicotine in this study was self-administered, exposure was brief 
(generally 1 hour per day), and amount of exposure was not systematically controlled in any 
way.  Given that self-administered nicotine has been shown to produce physiological effects 
quite different from those produced by experimenter-administered nicotine (Donny et al, 2000), 
further study should examine whether nicotine self-administered under carefully controlled 
conditions induces impulsive choice similar to that induced by experimenter-administered 
nicotine (Dallery & Locey, 2005). 
The nicotine self-administration paradigm used in the present study has been extensively 
characterized by previous work, demonstrating that nicotine acts as a primary reinforcer 
(Corrigall & Coen, 1989; Donny et al, 1998; Donny et al, 1999).  Accordingly, rats in the present 
study readily acquired self-administration as defined by earning a minimum of 5 infusions during 
the majority of sessions on a FR5, and as early as the first session rats favored the active nose 
poke over the inactive nose poke by a ratio of 2 to 1.  In addition, rats earned infusions at a rate 
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similar to other studies using a comparable cue and nicotine dose (Donny et al, 1999).  Individual 
differences in self-administration were also quite stable.  For example, the average number of 
infusions earned per session during week 3 of acquisition was highly correlated with average 
infusions earned per session during week 4 (r=.833, p<.001).  This suggests that individual 
differences in infusions earned reflect stable trait-like variability in the propensity to self-
administer nicotine, rather than random error.   
The progressive ratio test was designed to assess motivation to obtain nicotine or 
incentive salience of the drug (Donny et al., 1999; Richardson & Roberts, 1996). In the present 
study rats were responsive to the change in response contingency as expected, dramatically 
increasing their active nose poke responses relative to FR responding, while reducing the number 
of infusions earned.  Although dose was not manipulated on the PR schedule in the present 
study, the replication of previous work using the 0.03 dose (e.g. Donny et al, 1999) suggests that 
the current PR manipulation was effective at tapping into the motivation to obtain nicotine.  It is 
then most surprising that no group differences emerged during this phase of self-administration, 
as the incentive motivational properties of the drug are thought to be mediated by circuitry 
known to be relevant for discounting of delayed rewards (Hariri et al, 2006; McClure et al, 2004; 
Robinson & Berridge, 1993).  Several rats failed to reach a break point during the 4 hour PR test, 
effectively creating a ceiling for those animals.  It is possible that extending the length of the test 
would have revealed additional variance that may have been related to baseline impulsivity.  
However, given that on average over 70% of the animals did reach a break point, it is unlikely 
that this would have affected the results.        
Rats were also sensitive to changes in nicotine dose when returned to an FR schedule, 
significantly increasing the number of infusions earned at the 0.015 dose and decreasing the 
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number of infusions earned at the 0.09 dose, effectively titrating intake in a manner similar to 
that observed in other studies (Donny et al, 1999).  This finding is important, given that the dose-
response assessment was conducted within-subjects.  The similarity between the pattern of 
infusions earned in the present study and previous work conducted between-subjects supports the 
validity of a short-term within-subjects dose-response assessment.   
It is important to note that the selected doses did not yield a complete dose-response 
curve, since the number of infusions earned was at a peak at the lowest dose.  The absence of a 
sufficiently low dose to detect a decrease in responding prohibits us from evaluating whether or 
not impulsivity might be related to differences in sensitivity to nicotine.  Thus, it is possible that 
administration of a lower dose (e.g. 0.005) might have revealed group differences in responding 
that were not apparent at higher doses.  For example, while all rats would be expected to 
exhibited a decrease in infusions earned relative to the 0.015 dose, it is possible that high 
impulsivity could take more infusions than low impulsivity rats, demonstrating a greater 
sensitivity to nicotine which enables the low dose to retain some reinforcing properties.  
However, a true difference in sensitivity refers to a shift to the left of the dose-response curve 
(Piazza et al, 2000), such that group differences should have also been observed at the 0.09 dose 
if sensitivity to nicotine differed between groups.  In any case, the hypothesized vertical shift in 
the dose-response curve was effectively ruled out with the doses tested in the present study, 
indicating that there were no group differences in overall responsiveness to the reinforcing 
properties of nicotine.        
Finally, the lack of a significant effect was not due to inadequate power.  For example, 
impulsivity group explained approximately 2.2% of the variance in average break point during 
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sessions 2 and 3 on a progressive ratio schedule.  In order to achieve 80% power to detect an 
effect of this size, high and low impulsivity groups would have required approximately 190 rats 
each. 
It is surprising, given adequate power and valid and reliable measures, that no 
relationship was observed between level of impulsivity and any measure of nicotine self-
administration.  This suggests that delay discounting is not related to a susceptibility to the 
reinforcing properties of nicotine.  However, this does not necessarily preclude the possibility 
that smoking and delay discounting may be related to each other through a common neural 
substrate.  Instead, it is possible it is not nicotine reinforcement, but rather some other process 
relevant to smoking or nicotine-taking behavior, which shares a common neural substrate with 
delay discounting.  In order to further explore this possibility, it is important to consider how the 
current findings can be reconciled with investigations of other drugs of abuse and with the 
human smoking literature.   
The demonstration of a prospective relationship between delay discounting and 
subsequent self-administration of cocaine and alcohol (Perry et al, 2005; Poulos, Le, & Parker, 
1995) supports the hypothesis that, at least for some substances, drug self-administration and 
delay discounting share a common neural substrate.   If this hypothesis is correct, then the results 
of the present study indicate that either this can only be detected under certain self-administration 
conditions, or it is only true for some substances.  Thus, methodological differences in the 
measures used to assess self-administration or inherent differences between nicotine and cocaine 
and alcohol could both be factors contributing to the discrepancy in findings between research 
with other drugs of abuse and the present study.  Concerning methodological differences, Perry 
and colleagues (2005) primarily investigated the percentage of high and low impulsivity rats 
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which acquired cocaine self-administration using an auto-priming procedure.  In the present 
study, the simple nose poke operant and moderate nicotine dose used during acquisition were 
designed to maximize the number of rats which acquired self-administration and could undergo 
further testing.  Thus, it is possible that individual differences related to delay discounting could 
have been observed under conditions designed to exaggerate the variability in the number of rats 
acquiring self-administration, such as by using a lower dose of nicotine or more rapidly 
increasing the FR schedule.  However, both Perry et al (2005) and Poulos et al (1995) found 
significant differences in amount of cocaine and alcohol intake, respectively, between high and 
low impulsivity rats under stable self-administration conditions.  This suggests that even when 
stable responding on a FR schedule is being assessed, differences between drugs may yield quite 
different results.  For example, one potentially important difference between cocaine and 
nicotine is the demonstration that cocaine more readily produces dependence, as evidenced by 
compulsive, escalating use (Deroche, Le Moal, & Piazza, 1999).  
This raises the possibility that delay discounting may be more closely related to nicotine 
dependence than to nicotine use per se.  Indeed, this perspective is consistent with findings in the 
human literature.  Although some studies have found an association between delay discounting 
and quantity of use (Ohmura, Takahashi, & Kitamura, 2005; Heyman & Gibb, 2006), other 
studies have failed to replicate this effect (Johnson, Bickel, & Baker, 2007; Sweitzer et al, 2008).  
By contrast, nicotine dependence has been shown to be relatively dissociable from measures of 
use (Donny & Dierker, 2007), and a recent study demonstrated that delay discounting was 
related to dependence as measured by the FTND but not to cigarettes smoked per day (Sweitzer 
et al, 2008).  Although this finding awaits replication with other measures of nicotine 
dependence, the results are consistent with the current study.  Similarly, another recent human 
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study found that steeper discounting predicted smoking during an abstinence reinforcement 
paradigm (Dallery & Raiff, 2006).  This suggests that delay discounting may be an important 
marker for propensity to relapse—a construct central to dependence.  Although the responding 
on a PR schedule is thought to tap motivational processes likely to be relevant for dependence, it 
is possible that other measures or procedures designed to assess the construct of dependence 
might have revealed an association with delay discounting.  For example, previous studies have 
assessed behaviors such as persistence in responding for a drug during a signaled “no drug” 
period, continued self-administration despite aversive stimuli, and reinstatement of drug-seeking 
behavior following extinction (Deroche-Gamonet, Belin, & Piazza, 2004; Vanderschuren & 
Everitt, 2004).  Indeed, such behaviors tend to cluster together, even when no differences in 
reinforcement are detected during stable limited access self-administration (Deroche-Gamonet, 
Belin, & Piazza, 2004).  This suggests that these procedures are tapping into a common 
dependence construct that may not be apparent on a simple FR schedule.       
Although no studies had previously evaluated the prospective relationship between 
impulsivity and nicotine self-administration in rats, Diergaarde and colleagues (2008) recently 
published a study addressing this question.  They found that delay discounting failed to predict 
responding during self-administration on a FR schedule, but rats with steeper discounting 
extinguished their responses more slowly and made more active responses during reinstatement 
than less impulsive rats.   Delay discounting also predicted increased responding during a PR 
test, but this effect did not emerge until the 7th session.  These findings are partially consistent 
with the results of the current study.  Our results replicated the lack of an effect of delay 
discounting during FR self-administration.  However, contrary to the findings of Diergaarde et 
al, we did not find a relationship between delay discounting and infusions earned on a PR 
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schedule.  This could be due to methodological differences, as Diergaarde et al increased the 
response ratio over repeated sessions, rather than after each infusion within a single session.  
Indeed, the authors argue that the emergence of an effect of delay discounting during later PR 
sessions could be less of a reflection of motivation for the drug, and may instead be more closely 
related to the failure to inhibit responding during extinction.  The strongest effect of delay 
discounting observed in their study was during extinction and reinstatement, a test designed to 
assess persistence of drug-seeking and relapse following exposure to the drug or drug-related 
stimuli (Shaham et al, 2003).  These findings support the interpretation that delay discounting 
may be related to nicotine dependence rather than nicotine reinforcement.   
Collectively, this literature supports the hypothesis that smoking and delay discounting 
may be related to each other through a common neural substrate, and that delay discounting may 
be a marker for vulnerability to nicotine dependence.  This is particularly important given that 
traditional theories of dependence have relied on the explanation that drug exposure leads to 
changes in the brain which contribute to the development of dependence.  For example, 
Goldstein & Volkow (2002) posit that drug-induced deficits in prefrontal function lead to an 
impaired ability to inhibit drug seeking behavior—an important hallmark of addiction.  By 
contrast, the literature reviewed above suggests that delay discounting may be a marker for a pre-
existing susceptibility to dependence, which is likely linked to cortico-striatal-limbic circuitry.  
For example, individual variation in prefrontal inhibitory control pathways may predispose some 
individuals to develop dependence if they are exposed to a drug.  Understanding how variation in 
these neural pathways may confer risk for dependence is an important area for further 
exploration.  Phenotypic markers, like delay discounting, which may be associated with risk for 
dependence can provide a framework for both animal and human models to identify the 
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behavioral mechanisms and underlying neurocircuitry that contribute to vulnerability.  
Ultimately such efforts could be useful for increasing our understanding of the mechanisms 
underlying the development of nicotine dependence, and for facilitating the treatment and 
prevention of nicotine dependence for those most at risk. 
 
 
 
 
 
 41 
BIBLIOGRAPHY 
Adinoff, B. (2004). Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry, 
12(6), 305-320. 
Bickel, W. K., & Marsch, L. A. (2001). Toward a behavioral economic understanding of drug 
dependence: delay discounting processes. Addiction, 96(1), 73-86. 
Bickel, W. K., Odum, A. L., & Madden, G. J. (1999). Impulsivity and cigarette smoking: delay 
discounting in current, never, and ex-smokers. Psychopharmacology (Berl), 146(4), 447-
454. 
Bizot, J., Le Bihan, C., Puech, A. J., Hamon, M., & Thiebot, M. (1999). Serotonin and tolerance 
to delay of reward in rats. Psychopharmacology (Berl), 146(4), 400-412. 
Cardinal, R. N., Winstanley, C. A., Robbins, T. W., & Everitt, B. J. (2004). Limbic 
corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci, 1021, 33-50. 
Chassin, L., Presson, C. C., Pitts, S. C., & Sherman, S. J. (2000). The natural history of cigarette 
smoking from adolescence to adulthood in a midwestern community sample: multiple 
trajectories and their psychosocial correlates. Health Psychol, 19(3), 223-231. 
Chaudhri, N., Caggiula, A. R., Donny, E. C., Booth, S., Gharib, M., Craven, L., et al.. (2006). 
Self-administered and noncontingent nicotine enhance reinforced operant responding in 
rats: impact of nicotine dose and reinforcement schedule. Psychopharmacology (Berl). 
Coffey, S. F., Gudleski, G. D., Saladin, M. E., & Brady, K. T. (2003). Impulsivity and rapid 
discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin 
Psychopharmacol, 11(1), 18-25. 
Corrigall, W. A., Coen, K. M. (1989). Nicotine maintains robust self-administration in rats on a 
limited-access schedule. Psychopharmacology, 99(4), 473-478. 
Czoty, P. W., Ginsburg, B. C., & Howell, L. L. (2002). Serotonergic attenuation of the 
reinforcing and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp 
Ther, 300(3), 831-837. 
Dallery, J., & Locey, M. L. (2005). Effects of acute and chronic nicotine on impulsive choice in 
rats. Behav Pharmacol, 16(1), 15-23. 
 42 
Dallery, J., & Raiff, B. R. (2007). Delay discounting predicts cigarette smoking in a laboratory 
model of abstinence reinforcement. Psychopharmacology (Berl), 190(4), 485-496. 
Deroche, V., Le Moal, M., Piazza, P. V. (1999). Cocaine self-administration increases the 
incentive motivational properties of the drug in rats. European Journal of Neuroscience, 
11(8), 2731-2736. 
Deroche-Gamonet, V., Belin, D., & Piazza, P. V. (2004). Evidence for addiction-like behavior in 
the rat. Science, 305(5686), 1014-1017. 
Diergaarde, L., Pattij, T., Poortvliet, I., Hogenboom, F., de Vries, W., Schoffelmeer, A. N., et al. 
(2008). Impulsive choice and impulsive action predict vulnerability to distinct stages of 
nicotine seeking in rats. Biol Psychiatry, 63(3), 301-308. 
Donny, E. C., Caggiula, A. R., Mielke, M. M., Booth, S., Gharib, M. A., Hoffman, A., et al.. 
(1999). Nicotine self-administration in rats on a progressive ratio schedule of 
reinforcement. Psychopharmacology (Berl), 147(2), 135-142. 
Donny, E. C., Caggiula, A. R., Mielke, M. M., Jacobs, K. S., Rose, C., & Sved, A. F. (1998). 
Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, 
and drug contingency. Psychopharmacology (Berl), 136(1), 83-90. 
Donny, E. C., Caggiula, A. R., Rowell, P. P., Gharib, M. A., Maldovan, V., Booth, S., et al.. 
(2000). Nicotine self-administration in rats: estrous cycle effects, sex differences and 
nicotinic receptor binding. Psychopharmacology (Berl), 151(4), 392-405. 
Donny, E. C., & Dierker, L. C. (2007). The absence of DSM-IV nicotine dependence in 
moderate-to-heavy daily smokers. Drug Alcohol Depend, 89(1), 93-96. 
Donny, E. C., Lanza, S. T., Balster, R. L., Collins, L. M., Caggiula, A., & Rowell, P. P. (2004). 
Using growth models to relate acquisition of nicotine self-administration to break point 
and nicotinic receptor binding. Drug Alcohol Depend, 75(1), 23-35. 
Goldstein, R. Z., & Volkow, N. D. (2002). Drug addiction and its underlying neurobiological 
basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry, 
159(10), 1642-1652. 
Green, L., & Myerson, J. (2004). A discounting framework for choice with delayed and 
probabilistic rewards. Psychol Bull, 130(5), 769-792. 
Grottick, A. J., Corrigall, W. A., & Higgins, G. A. (2001). Activation of 5-HT(2C) receptors 
reduces the locomotor and rewarding effects of nicotine. Psychopharmacology (Berl), 
157(3), 292-298. 
Hariri, A. R., Brown, S. M., Williamson, D. E., Flory, J. D., de Wit, H., & Manuck, S. B. (2006). 
Preference for immediate over delayed rewards is associated with magnitude of ventral 
striatal activity. J Neurosci, 26(51), 13213-13217. 
 43 
Heyman, G. M., & Gibb, S. P. (2006). Delay discounting in college cigarette chippers. Behav 
Pharmacol, 17(8), 669-679. 
Jentsch, J. D., & Taylor, J. R. (1999). Impulsivity resulting from frontostriatal dysfunction in 
drug abuse: implications for the control of behavior by reward-related stimuli. 
Psychopharmacology (Berl), 146(4), 373-390. 
Johnson, M. W., Bickel, W. K., & Baker, F. (2007). Moderate drug use and delay discounting: a 
comparison of heavy, light, and never smokers. Exp Clin Psychopharmacol, 15(2), 187-
194. 
Kirby, K. N., Petry, N. M., & Bickel, W. K. (1999). Heroin addicts have higher discount rates for 
delayed rewards than non-drug-using controls. J Exp Psychol Gen, 128(1), 78-87. 
Lanza, S. T., Donny, E. C., Collins, L. M., & Balster, R. L. (2004). Analyzing the acquisition of 
drug self-administration using growth curve models. Drug Alcohol Depend, 75(1), 11-21. 
Le, A. D., Li, Z., Funk, D., Shram, M., Li, T. K., & Shaham, Y. (2006). Increased vulnerability 
to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively 
bred for high alcohol intake. J Neurosci, 26(6), 1872-1879. 
Madden, G. J., Petry, N. M., Badger, G. J., & Bickel, W. K. (1997). Impulsive and self-control 
choices in opioid-dependent patients and non-drug-using control participants: drug and 
monetary rewards. Exp Clin Psychopharmacol, 5(3), 256-262. 
Mantsch, J. R., Ho, A., Schlussman, S. D., & Kreek, M. J. (2001). Predictable individual 
differences in the initiation of cocaine self-administration by rats under extended-access 
conditions are dose-dependent. Psychopharmacology (Berl), 157(1), 31-39. 
Manuck, S. B., Flory, J. D., Muldoon, M. F., & Ferrell, R. E. (2003). A neurobiology of 
intertemporal choice. In Time and decision: Economic and psychological perspectives on 
intertemporal choice (pp. 139-172). New York, NY: Russell Sage Foundation. 
Mazur, J. E. (1987). An adjusting procedure for studying delayed reinforcement. In The effect of 
delay and of intervening events on reinforcement value (pp. 55-73). Hillsdale, NJ, 
England: Lawrence Erlbaum Associates, Inc. 
McClure, S. M., Laibson, D. I., Loewenstein, G., & Cohen, J. D. (2004). Separate neural systems 
value immediate and delayed monetary rewards. Science, 306(5695), 503-507. 
Mitchell, S. H. (1999). Measures of impulsivity in cigarette smokers and non-smokers. 
Psychopharmacology (Berl), 146(4), 455-464. 
Mitchell, S. H., Reeves, J. M., Li, N., & Phillips, T. J. (2006). Delay discounting predicts 
behavioral sensitization to ethanol in outbred WSC mice. Alcohol Clin Exp Res, 30(3), 
429-437. 
 44 
Mobini, S., Chiang, T. J., Al-Ruwaitea, A. S., Ho, M. Y., Bradshaw, C. M., & Szabadi, E. 
(2000). Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a 
quantitative analysis. Psychopharmacology (Berl), 149(3), 313-318. 
Ohmura, Y., Takahashi, T., & Kitamura, N. (2005). Discounting delayed and probabilistic 
monetary gains and losses by smokers of cigarettes. Psychopharmacology (Berl), 182(4), 
508-515. 
Olausson, P., Engel, J. A., & Soderpalm, B. (2002). Involvement of serotonin in nicotine 
dependence: processes relevant to positive and negative regulation of drug intake. 
Pharmacol Biochem Behav, 71(4), 757-771. 
Perry, J. L., Larson, E. B., German, J. P., Madden, G. J., & Carroll, M. E. (2005). Impulsivity 
(delay discounting) as a predictor of acquisition of IV cocaine self-administration in 
female rats. Psychopharmacology (Berl), 178(2-3), 193-201. 
Petry, N. M. (2001). Pathological gamblers, with and without substance use disorders, discount 
delayed rewards at high rates. J Abnorm Psychol, 110(3), 482-487. 
Piazza, P. V., Deminiere, J. M., Le Moal, M., & Simon, H. (1989). Factors that predict individual 
vulnerability to amphetamine self-administration. Science, 245(4925), 1511-1513. 
Piazza, P. V., Deroche-Gamonent, V., Rouge-Pont, F., & Le Moal, M. (2000). Vertical shifts in 
self-administration dose-response functions predict a drug-vulnerable phenotype 
predisposed to addiction. J Neurosci, 20(11), 4226-4232. 
Pierucci, M., Di Matteo, V., & Esposito, E. (2004). Stimulation of serotonin2C receptors blocks 
the hyperactivation of midbrain dopamine neurons induced by nicotine administration. J 
Pharmacol Exp Ther, 309(1), 109-118. 
Poulos, C. X., Le, A. D., & Parker, J. L. (1995). Impulsivity predicts individual susceptibility to 
high levels of alcohol self-administration. Behav Pharmacol, 6(8), 810-814. 
Poulos, C. X., Parker, J. L., & Le, D. A. (1998). Increased impulsivity after injected alcohol 
predicts later alcohol consumption in rats: evidence for "loss-of-control drinking" and 
marked individual differences. Behav Neurosci, 112(5), 1247-1257. 
Reynolds, B., Richards, J. B., Horn, K., & Karraker, K. (2004). Delay discounting and 
probability discounting as related to cigarette smoking status in adults. Behav Processes, 
65(1), 35-42. 
Richards, J. B., Mitchell, S. H., de Wit, H., & Seiden, L. S. (1997). Determination of discount 
functions in rats with an adjusting-amount procedure. J Exp Anal Behav, 67(3), 353-366. 
Richardson, N. R., & Roberts, D. C. (1996). Progressive ratio schedules in drug self-
administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci 
Methods, 66(1), 1-11. 
 45 
Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: an incentive-
sensitization theory of addiction. Brain Res Brain Res Rev, 18(3), 247-291. 
Schultz, W. (2002). Getting formal with dopamine and reward. Neuron, 36(2), 241-263. 
Shaham, Y., Shalev, U., Lu, L., De Wit, H., & Stewart, J. (2003). The reinstatement model of 
drug relapse: history, methodology and major findings. Psychopharmacology (Berl), 
168(1-2), 3-20. 
Skinner, M. D., Aubin, H. J., & Berlin, I. (2004). Impulsivity in smoking, nonsmoking, and ex-
smoking alcoholics. Addict Behav, 29(5), 973-978. 
Stanton, W. R., Flay, B. R., Colder, C. R., & Mehta, P. (2004). Identifying and predicting 
adolescent smokers' developmental trajectories. Nicotine Tob Res, 6(5), 843-852. 
Suto, N., Austin, J. D., & Vezina, P. (2001). Locomotor response to novelty predicts a rat's 
propensity to self-administer nicotine. Psychopharmacology (Berl), 158(2), 175-180. 
Sweitzer, M. M., Donny, E. C., Dierker, L. C., Flory, J. D., & Manuck, S. B. (2008). Delay 
discounting and smoking: Association with Fagerstrom Test for Nicotine Dependence but 
not cigarettes smoked per day. Nicotine & Tobacco Research, 10(10):1571-1575.  
Vanderschuren, L. J., & Everitt, B. J. (2004). Drug seeking becomes compulsive after prolonged 
cocaine self-administration. Science, 305(5686), 1017-1019. 
Vezina, P. (2004). Sensitization of midbrain dopamine neuron reactivity and the self-
administration of psychomotor stimulant drugs. Neurosci Biobehav Rev, 27(8), 827-839. 
Vuchinich, R. E., & Simpson, C. A. (1998). Hyperbolic temporal discounting in social drinkers 
and problem drinkers. Exp Clin Psychopharmacol, 6(3), 292-305. 
Wogar, M. A., Bradshaw, C. M., & Szabadi, E. (1993). Effect of lesions of the ascending 5-
hydroxytryptaminergic pathways on choice between delayed reinforcers. 
Psychopharmacology (Berl), 111(2), 239-243. 
Wolff, M. C., & Leander, J. D. (2002). Selective serotonin reuptake inhibitors decrease 
impulsive behavior as measured by an adjusting delay procedure in the pigeon. 
Neuropsychopharmacology, 27(3), 421-429. 
 
